
Join to View Full Profile
1275 York AveBox 27New York, NY 10065
Phone+1 469-363-8500
Dr. Shariat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterResidency, Urology, 2003 - 2008
University of Vienna Faculty of MedicineClass of 1998
Certifications & Licensure
NY State Medical License 2010 - 2015
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsEffect of Marital Status on Years of Life Lost From Metastatic Prostate Cancer According to Race/Ethnicity.Leonardo Quarta, Federico Polverino, Michele Petix, Maximilian Filzmayer, Nick J Lee
The Prostate. 2026-05-01 - Efficacy and tolerability of hypofractionated and dose-boosted radiotherapy for localised prostate cancer: a systematic review and meta-analysis.Marcin Miszczyk, Nishan Sohoni, Shayan Smani, Matthias Moll, Ahmed R Alfarhan
Radiotherapy and Oncology. 2026-05-01 - Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort study.Paolo Zaurito, Pietro Scilipoti, Mattia Longoni, Mario de Angelis, Aleksander Ślusarczyk
Urologic Oncology. 2026-04-02
Journal Articles
- External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-Based An...Shahrokh Shariat, MD, European Urology
- Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-Institutional AnalysisShahrokh Shariat, Inderbir S Gill, European Urology
- Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate CancerShahrokh Shariat, MD, European Urology
Authored Content
- A Urinary microRNA (miR) Signature for Diagnosis of Bladder CancerOctober 2018
- A Urinary microRNA (miR) Signature for Diagnosis of Bladder CancerOctober 2018
- Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-Risk Prostate Cancer: Results from the Prospective Randomised, Open-Label Phase 3 Scandinavian Prostate Cancer Group 12 TrialJuly 2018
Press Mentions
Adding ARPIs to ADT Raises CV Event Risk in Prostate CancerOctober 21st, 2025
Variant Histology Worsens UTUC Outcomes, Study FindsSeptember 5th, 2019
This Urologist Studies Adult Film Entertainers to Solve Sexual DysfunctionMay 17th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









